According to the latest report published by Credence Research, Inc. “Percutaneous Coronary Intervention Devices Market By Device Type (Coronary Stents, PTCA Catheters, Coronary Guidewires), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Catheterization Labs) – Growth, Future Prospects and Competitive Analysis, 2018-2026,” the worldwide market for percutaneous coronary intervention instruments was estimated at $5.98 billion in 2017 and is anticipated to reach $8.70 billion by 2026, growing by 4.3% from 2018 to 2026.
Browse the full report at https://www.acutemarketreports.com/report/percutaneous-coronary-intervention-pci-devices-market
The worldwide market for percutaneous coronary intervention instruments is valued at US$ 5.98 billion for 2017, driven primarily by rising worldwide burden of heart disease, diabetes, and coronary artery disease. Percutaneous coronary intervention is a non-surgical technique to prevent coronary artery narrowing by removing the plaque using PTCA balloon catheters and coronary stent placement. An approximately 15.5 million people over the age of 20 had coronary artery disease in 2015, and this number is anticipated to continue to develop in the future, according to the American Heart Association. Other significant factors contributing to the increase in the amount of percutaneous coronary intervention processes include decreased likelihood of complications and diseases compared to standard techniques of therapy. The absence of qualified experts to execute the processes, however, hinders the development of the worldwide market for percutaneous coronary intervention instruments.
The worldwide market for percutaneous coronary intervention systems is divided into coronary stents, PTCA catheters, and coronary guidewires based on device kinds. These instruments are used during PCI processes to treat coronary artery disease. Due to the advent of fresh products on the market, the coronary stents segment is anticipated to develop at a significant rate in the forecast period.Based on the end-users, the global percutaneous coronary intervention devices market is segmented into hospitals, ambulatory surgical centers (ASCs), and catheterization labs. In terms of market value, hospitals segment is expected to dominate the global percutaneous coronary intervention devices market for the year 2017 due to greater availability of the skilled professionals required to perform the procedure, and greater footfall of target patients in hospitals. However, as the healthcare infrastructure is expanding in both developed and developing economies, and greater preference for specialized treatment locations is observed in both patients and care-givers, the dominance of hospitals is expected to be challenged by catheterization labs.
Based on the geographical segmentation, North America is expected to dominate the global percutaneous coronary intervention devices market for the year 2017 due to greater awareness of the general population about management of heart diseases, and better reimbursement scenario. However, proliferation of medical tourism and the flourishing healthcare market in Asia Pacific will make the region progress at a faster growth rate than the global benchmark. Market players have varied product portfolio from offering only stents to sporting the entire portfolio for PCI. Major players in the global percutaneous coronary intervention devices market include Abbott Laboratories, Inc., B. Braun Melsungen AG, Biosensors International Group, Biotronik SE & Co. KG, Boston Scientific Corporation, Getinge AB, Johnson & Johnson, Medtronic plc, St. Jude Medical LLC, and Terumo Corporation.
Download Free PDF Sample Request: https://www.acutemarketreports.com/sample-request/58198
By Device Type
- Coronary Stents
- PTCA Catheters
- Coronary Guidewires
By End User Type
- Ambulatory Surgical Centers (ASCs)
- Catheterization Labs
By Geography Segment
- North America
- Asia Pacific (APAC)
- Middle East & Africa (MEA)
- Latin America
Acute Market Reports is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
Toll-Free (US/CANADA) Ph.: +1-800-361-8290